HRTX May 2024 4.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:08PM EDT. Market open.
| Previous close | 1.3500 |
| Open | N/A |
| Bid | 0.2500 |
| Ask | 1.2000 |
| Strike | 4.00 |
| Expiry date | 2024-05-17 |
| Day's range | 1.3500 - 1.3500 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksFDA Delays Decision on Ascendis' (ASND) Hormone Therapy Filing
Per the FDA, the data submitted by Ascendis (ASND) for its hormone replacement therapy constitutes a major amendment to its previously-submitted data. A final decision is expected by Aug 14.
Simply Wall St.Heron Therapeutics, Inc. (NASDAQ:HRTX) Just Released Its First-Quarter Earnings: Here's What Analysts Think
A week ago, Heron Therapeutics, Inc. ( NASDAQ:HRTX ) came out with a strong set of quarterly numbers that could...
Insider MonkeyHeron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript
Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript May 7, 2024 Heron Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.0209, expectations were $-0.08. HRTX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Thank you for standing by. My […]
© 2024 Yahoo. All rights reserved.